Versant Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11
| Closed | -$115 | – | 2701 |
|
|
2025
Q1 | $115 | Hold |
11
| – | – | ﹤0.01% | 2484 |
|
|
2024
Q4 | $157 | Hold |
11
| – | – | ﹤0.01% | 2342 |
|
|
2024
Q3 | $220 | Hold |
11
| – | – | ﹤0.01% | 1956 |
|
|
2024
Q2 | $210 | Hold |
11
| – | – | ﹤0.01% | 1900 |
|
|
2024
Q1 | $158 | Hold |
11
| – | – | ﹤0.01% | 1846 |
|
|
2023
Q4 | $95 | Sell |
11
-39
| -78% | -$337 | ﹤0.01% | 1898 |
|
|
2023
Q3 | $448 | Hold |
50
| – | – | ﹤0.01% | 1713 |
|
|
2023
Q2 | $433 | Hold |
50
| – | – | ﹤0.01% | 1864 |
|
|
2023
Q1 | $478 | Sell |
50
-148
| -75% | -$1.42K | ﹤0.01% | 1588 |
|
|
2022
Q4 | $6.7K | Buy |
198
+121
| +157% | +$4.09K | ﹤0.01% | 793 |
|
|
2022
Q3 | $4K | Buy |
77
+28
| +57% | +$1.46K | ﹤0.01% | 912 |
|
|
2022
Q2 | $3K | Buy |
49
+13
| +36% | +$796 | ﹤0.01% | 1009 |
|
|
2022
Q1 | $3K | Buy |
36
+35
| +3,500% | +$2.92K | ﹤0.01% | 1049 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1539 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1544 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1548 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1574 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1467 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1436 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1475 |
|
|
2020
Q1 | $0 | Sell |
1
-2
| -67% | – | ﹤0.01% | 1559 |
|
|
2019
Q4 | $1K | Hold |
3
| – | – | ﹤0.01% | 1252 |
|
|
2019
Q3 | $0 | Sell |
3
-2
| -40% | – | ﹤0.01% | 1519 |
|
|
2019
Q2 | $2K | Sell |
5
-11
| -69% | -$4.4K | ﹤0.01% | 1194 |
|
|
2019
Q1 | $8K | Sell |
16
-48
| -75% | -$24K | ﹤0.01% | 985 |
|
|
2018
Q4 | $31K | Sell |
64
-6
| -9% | -$2.91K | 0.01% | 372 |
|
|
2018
Q3 | $63K | Sell |
70
-58
| -45% | -$52.2K | 0.03% | 234 |
|
|
2018
Q2 | $93K | Sell |
128
-12
| -9% | -$8.72K | 0.04% | 162 |
|
|
2018
Q1 | $223K | Sell |
140
-16
| -10% | -$25.5K | 0.09% | 94 |
|
|
2017
Q4 | $139K | Buy |
156
+21
| +16% | +$18.7K | 0.06% | 121 |
|
|
2017
Q3 | $48K | Buy |
135
+58
| +75% | +$20.6K | 0.03% | 265 |
|
|
2017
Q2 | $22K | Buy |
77
+29
| +60% | +$8.29K | 0.01% | 558 |
|
|
2017
Q1 | $16K | Buy |
48
+47
| +4,700% | +$15.7K | 0.01% | 666 |
|
|
2016
Q4 | $0 | Sell |
1
-3
| -75% | – | ﹤0.01% | 1480 |
|
|
2016
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 1453 |
|
|
2016
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 1408 |
|
|
2016
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 1417 |
|
|
2015
Q4 | $0 | Buy |
+4
| New | – | ﹤0.01% | 1405 |
|